Deion Sanders’ Cancer Diagnosis: Here’s What to Know
After encountering treatment options “that scared me to death,” NFL Hall of Famer Deion Sanders anticipates a full recovery from bladder cancer and returning to the sidelines as head coach of the University of Colorado Buffaloes. Like so many cancers, his was discovered during routine follow-up; in his case, for a previous bout of blood […]
Clinical Challenges: Sequencing in Metastatic TNBC
As new treatment options continue to emerge for triple-negative breast cancer (TNBC), sequencing of therapy promises to get ever more complicated. TNBC had been estimated to account for about 15% of all breast cancer diagnoses, but that proportion shrank with the new HER2-low designation, which accounts for approximately one-third of patients diagnosed with TNBC. An […]
Clinical Challenges: Test Your Knowledge on New Breast Cancer Treatments
The number of available treatment options for patients newly diagnosed with breast cancer continues to grow. The following three-question quiz will test one aspect from each article in our “Clinical Challenges” series on advanced breast cancer, which covered managing adverse effects of novel therapies and sequencing of treatments in metastatic HER2-positive breast cancer and metastatic […]
Making plant-based meat more ‘meaty’ — with fermented onions
Plant-based alternatives such as tempeh and bean burgers provide protein-rich options for those who want to reduce their meat consumption. However, replicating meat’s flavors and aromas has proven challenging, with companies often relying on synthetic additives. A recent study in ACS’ Journal of Agricultural and Food Chemistry unveils a potential solution: onions, chives and leeks […]
FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamab
Treatment options for relapsed/refractory multiple myeloma continue to expand with FDA’s accelerated approval of teclistamab (Tecvayli). The approval stipulates use of the bispecific antibody in adults who have received at least four prior therapies, including an immunomodulator, a proteasome inhibitor, and an anti-CD38 antibody (triple-class refractory disease). The first approved drug of its kind, teclistamab […]
Top 10 Highest Paying Healthcare Jobs
[embedded content] There are many different career options within healthcare, each with their own unique roles and responsibilities, but which ones pay you the most for your time? Although money should never be your primary motivation when choosing a career, it is still an important part of the decision-making process. Another important factor to consider, […]
What Is the Best Treatment for Mental Illness? (8 Options)
8 treatment options for mental illnesses Taking care of your mental health means creating a balance between life activities and responsibilities, as well as the following 8 treatment options. Mental health and stress management are important aspects that can save your ability to appreciate life and affect your productivity. Taking care of your mental health […]
International study supports dupilumab for treatment of moderate-to-severe asthma in children
A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11. The findings of the international multicenter Liberty Asthma VOYAGE trial, reported […]
What’s The Deal With Anxiety Rings And Do They Help Symptoms?
When it comes to managing symptoms of anxiety, there are a lot of options out there. Meditation, cognitive behavioral therapy and medication — prescribed under the guidance of a doctor, of course — are a few of them. One lesser-known method? Anxiety rings. Anxiety rings might sound high tech, but they’re really not: Most are […]
ADT Options for Prostate Cancer Come Out Even for Heart Safety
Androgen deprivation therapy (ADT) options for prostate cancer seemed to have a similar impact on the risk of cardiovascular events among people with documented heart disease, according to results from the PRONOUNCE trial, although the study was terminated early due to slow accrual. In 545 men, there was no statistically significant difference in the rate […]